Inventor · disambiguated record
Brenda K. Mann
Also filed as: MANN BRENDA · MANN BRENDA K
9 granted patents·6 pending applications·76 citations·filing 2001–2024
85Inventor score
Files withGERTON MARINA LEE3MANN BRENDA K3EYEGATE PHARMACEUTICALS INC2KIORA PHARMACEUTICALS INC2UNIV RICE WILLIAM M2
Top patents by PatentIndex Score
15 records- 0192US7780897B2Hydrogel constructs using stereolithographyUNIV TEXAS·Filed 2005·Granted Aug 24, 2010·29 cites·25 claims
- 0287US7635592B2Tissue engineering scaffolds promoting matrix protein productionRICE UNIVERSITY·Filed 2001·Granted Dec 22, 2009·26 cites·20 claims
- 0379US8197743B2Hydrogel constructs using stereolithographyWICKER RYAN·Filed 2010·Granted Jun 12, 2012·20 cites·15 claims
- 0474US12251467B2Vaginal hydrogel for delivery of therapeuticsGERTON MARINA LEE·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 0573US2024165238A1Vaginal HydrogelMANN BRENDA K·Filed 2024·Application pending·0 cites
- 0670US11911479B2Vaginal hydrogelMANN BRENDA K·Filed 2022·Granted Feb 27, 2024·0 cites·12 claims
- 0770US11376214B2Compositions and methods for treatment of ocular diseasesKIORA PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·1 cites·27 claims
- 0864US11701324B2Vaginal hydrogel for delivery of therapeuticsGERTON MARINA LEE·Filed 2021·Granted Jul 18, 2023·0 cites·20 claims
- 0964US10959945B2Vaginal hydrogel for delivery of therapeuticsGERTON MARINA LEE·Filed 2018·Granted Mar 30, 2021·0 cites·20 claims
- 1063US11419941B2Vaginal hydrogelMANN BRENDA K·Filed 2018·Granted Aug 23, 2022·0 cites·15 claims
- 1156US2005158357A1Tissue engineering scaffolds promoting martix protein productionUNIV RICE WILLIAM M·Filed 2004·Application pending·0 cites
- 1256US2005158358A1Tissue engineering scaffolds promoting matrix protein productionUNIV RICE WILLIAM M·Filed 2004·Application pending·0 cites
- 1355US2022287961A1Compositions and methods for treatment of ocular diseasesKIORA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1445US2021299039A1Compositions and methods for treating ocular disease by contact lens mediated drug deliveryEYEGATE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1545US2021290527A1Compositions and Methods for Treatment of Ocular ConditionsEYEGATE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brenda K. Mann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →